Genic Co., Ltd. (KOSDAQ:123330)

South Korea · Delayed Price · Currency is KRW

33,400

-1,400 (-4.02%)

At close: Sep 3, 2026

Market Cap	249.61B +12.7%
Revenue (ttm)	114.29B +48.3%
Net Income	26.06B +74.7%
EPS	3,331.10 +73.9%
Shares Out	7.82M
PE Ratio	9.58
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214,636
Open	34,700
Previous Close	34,800
Day's Range	32,600 - 36,300
52-Week Range	15,570 - 38,900
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Genic

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and ... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations

Founded 2001

Employees 324

Stock Exchange KOSDAQ

Ticker Symbol 123330

Full Company Profile

Financial Performance

In 2025, Genic's revenue was 78.20 billion, an increase of 56.68% compared to the previous year's 49.91 billion. Earnings were 18.89 billion, an increase of 149.73%.

Financial Statements